Moody's Downgrades Valeant Pharma (VRX) CFR to B3 from B2; Outlook Negative

Go back to Moody's Downgrades Valeant Pharma (VRX) CFR to B3 from B2; Outlook Negative

Form 8-K Valeant Pharmaceuticals For: Nov 08

November 8, 2016 6:09 AM EST

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

... More